Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from American Healthcare REIT, Inc. ( (AHR) ) is now available.
On August 7, 2025, American Healthcare REIT, Inc. announced its second quarter 2025 results, reporting a GAAP net income of $9.9 million and a significant growth in Same-Store Net Operating Income (NOI) of 13.9% compared to the same period in 2024. The company increased its full-year 2025 guidance due to strong performance in its senior housing and integrated senior health campuses segments. The company also completed several acquisitions and sales, including the purchase of a new senior housing operating property for $65 million and issuing shares through its equity offering program, raising substantial capital. These strategic moves are expected to enhance the company’s financial position and support its mission of providing high-quality care.
The most recent analyst rating on (AHR) stock is a Buy with a $34.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.
Spark’s Take on AHR Stock
According to Spark, TipRanks’ AI Analyst, AHR is a Neutral.
American Healthcare REIT, Inc. shows strong technical momentum and stable shareholder returns through dividends, which are significant strengths. However, profitability issues and a negative P/E ratio weigh heavily on its valuation, resulting in a moderate overall stock score.
To see Spark’s full report on AHR stock, click here.
More about American Healthcare REIT, Inc.
American Healthcare REIT, Inc. operates in the healthcare real estate industry, focusing on senior housing and integrated senior health campuses. The company is involved in acquiring, managing, and developing healthcare properties, with a significant emphasis on senior living facilities.
Average Trading Volume: 1,590,477
Technical Sentiment Signal: Buy
Current Market Cap: $6.47B
For a thorough assessment of AHR stock, go to TipRanks’ Stock Analysis page.